Table 1 Baseline characteristics and outcomes of the low- and high-IAP groups.
Low-IAP | High-IAP | P value | |
|---|---|---|---|
n | 317 | 504 | |
Baseline characteristics | |||
Age (Year) | 61.49 (16.58) | 61.87 (14.75) | 0.751 |
Male (%) | 184 (58.0) | 333 (66.1) | 0.025 |
ICU-type (%) | 0.131 | ||
CCU | 46 (14.5) | 79 (15.7) | |
SICU | 185 (58.4) | 259 (51.4) | |
Other | 86 (27.1) | 166 (32.9) | |
Weight (Kg) | 83.04 (19.68) | 87.85 (20.45) | 0.001 |
SOFA | 9.0 (5.0 to 12.0) | 10.0 (6.0 to 13.0) | 0.001 |
SAPSII | 48.0 (35.0 to 61.0) | 50.0 (38.0 to 62.0) | 0.092 |
CCI (%) | 5.0 (2.0 to 7.0) | 4.0 (3.0 to 7.0) | 0.252 |
CHF (%) | 47 (14.8) | 85 (16.9) | 0.499 |
CKD (%) | 54 (17.0) | 91 (18.1) | 0.78 |
Diabetes (%) | 91 (28.7) | 122 (24.2) | 0.177 |
Sepsis (%) | 266 (83.9) | 430 (85.3) | 0.656 |
Vasopressor (%) | 93 (29.3) | 163 (32.3) | 0.408 |
Invasive MV (%) | 242 (76.3) | 383 (76.0) | 0.976 |
Hemoglobin(g/L) | 9.27 (2.01) | 9.22 (2.11) | 0.825 |
WBC (*109) | 15.94 (7.97) | 15.68 (7.78) | 0.618 |
Creatinine(mg/dl) | 1.1 (0.7 to 2.0) | 1.3 (0.9 to 2.1) | 0.050 |
Outcome | |||
AKI (%) | 142 (44.8) | 274 (54.4) | 0.009 |
Stage1 (%) | 71 (22.4) | 137 (27.2) | 0.05 |
Stage2 (%) | 43 (13.6) | 82 (16.3) | 0.03 |
Stage3 (%) | 28 (8.8) | 55 (10.9) | 0.01 |
CRRT (%) | 89(28.1) | 188(37.2) | 0.012 |
28-day mortality (%) | 83(26.2) | 186(36.9) | 0.008 |